![electric vehicle at charging point](https://www.morningstar.co.uk/static/UploadManager/Assets/Electric%20smart%20car%20800px.jpg)
Electric vehicles and hybrids will be two of every three cars sold globally by 2030
![Tesla superchargers](https://morningstar-morningstar-prod.web.arc-cdn.net/resizer/iAeb-aR8z8Y-g55J2wF9wuqQKs4=/640x0/filters:no_upscale():quality(80)/cloudfront-us-east-1.images.arcpublishing.com/morningstar/347BSP2KJNBCLKVD7DGXSFLDLU.jpg)
Investors should wait for a larger pullback before buying
![Tesla UK Main](https://images.contentstack.io/v3/assets/blt4eb669caa7dc65b2/blt9986a3cba2c7a0e4/62e92f43d244a471dace672d/Tesla.jpg)
Watching companywide operating profit margins, affordability, and full self-driving software updates
-
Are FTSE Mining Companies Cheap Right Now?
Mining companies are operating in a challenging environment but could now be the time to top up o...
-
Advice for George Osborne and Stock Market Regrets
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an...
-
How to Find Solid Dividend-Paying Stocks
Businesses that have competitive advantages within their industry are good candidates for dividen...
-
10 Top-Performing Funds in the UK
Morningstar reveals the top 10 best performers over the last five years
-
Fund Research: Europe’s Shining Stars
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
-
NatWest Shares Up as Profits Beat Expectations
The bank also announced a deal with Metro Bank, raised its guidance, and increased its dividends
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
With revenue growth, increased operating margins, but a high valuation, here’s what we think of N...
-
Going into Earnings, is Apple Stock a Buy, Sell, or Hold?
We'll be watching iPhone revenue, gross margins, and services growth when Apple reports its earni...
-
Unilever Earnings: Growth in a Challenging Market
Despite growth, Morningstar's Fair Value Estimate for the consumer goods giant stock is unchanged
-
AstraZeneca Earnings: Steady Outlook but Growth Could Slow
Morningstar analysts think the UK's biggest company has a well-positioned broad drug portfolio wh...